Interleukin-10 promoter polymorphism IL10.G and familial early onset psoriasis
- PMID: 12932247
- DOI: 10.1046/j.1365-2133.2003.05411.x
Interleukin-10 promoter polymorphism IL10.G and familial early onset psoriasis
Abstract
Background: The anti-inflammatory cytokine interleukin (IL)-10 is considered to play a major role in the pathophysiology of psoriasis, which is characterized by an IL-10 deficiency. Systemic administration of IL-10 has been shown to be an effective therapy for psoriasis. The IL-10 promoter region contains a highly polymorphic microsatellite (IL10.G) and in a recent case-control study the IL10.G13 (144 bp) allele was found to be associated with familial early onset psoriasis (type 1 psoriasis) having a susceptible effect.
Objectives: As it is essential in multifactorial diseases to replicate findings before definite conclusions can be drawn, we decided to perform a follow-up study and to follow a genetic approach analysing allele transmission in families with a positive family history of psoriasis.
Methods: We studied 137 nuclear families (trio-design) comprising 456 individuals and genotyped the IL10.G marker. For comparison we also genotyped the microsatellite tn62 as a reference marker of the major psoriasis susceptibility locus on chromosome 6p21 (PSORS1). In the present study allele transmission was evaluated using the family-based association test (FBAT) and GENEHUNTER 2.0 based on the transmission/disequilibrium test.
Results: The G13 allele (144 bp) had a frequency of 24%, was present in 88 families and clearly showed an even transmission (FBAT, P = 0.753). In contrast, allele 3 (IL10.G9) (136 bp) had a frequency of 39%, was present in 110 families and was transmitted in 43 trios and remained untransmitted in 67 trios (FBAT, P = 0.026), thus showing preferential nontransmission. For the HLA-linked tn62-marker we obtained a P-value of 0.00027 for allele 4 in the same study group.
Conclusions: In conclusion, we failed to confirm the susceptible effect of the G13 allele, but provide the first data for a protective effect of allele 3 (IL10.G9) for familial psoriasis. Our results suggest that the IL10.G polymorphism is not a major locus, but acts as a minor locus.
Similar articles
-
Interleukin-10 promoter polymorphism in psoriasis.J Invest Dermatol. 2001 Jun;116(6):975-8. doi: 10.1046/j.1523-1747.2001.01350.x. J Invest Dermatol. 2001. PMID: 11407990
-
Interleukin 10.G microsatellite in the promoter region of the interleukin-10 gene in severe sepsis.Chin Med J (Engl). 2006 Feb 5;119(3):197-201. Chin Med J (Engl). 2006. PMID: 16537004
-
Interleukin-10 promoter microsatellite polymorphisms in systemic lupus erythematosus: association with the anti-Sm immune response.Rheumatology (Oxford). 2004 Nov;43(11):1357-63. doi: 10.1093/rheumatology/keh353. Epub 2004 Aug 10. Rheumatology (Oxford). 2004. PMID: 15304673
-
Interleukin 6-174 G/C promoter gene polymorphism and sporadic Alzheimer's disease: geographic allele and genotype variations in Europe.Exp Gerontol. 2004 Oct;39(10):1567-73. doi: 10.1016/j.exger.2004.07.006. Exp Gerontol. 2004. PMID: 15501028 Review.
-
Interleukin 10 promotor gene polymorphism in the pathogenesis of psoriasis.Acta Dermatovenerol Alp Pannonica Adriat. 2019 Sep;28(3):119-123. Acta Dermatovenerol Alp Pannonica Adriat. 2019. PMID: 31545389 Review.
Cited by
-
Associations between interleukin-10 polymorphisms and susceptibility to psoriasis: a meta-analysis.Inflamm Res. 2012 Jul;61(7):657-63. doi: 10.1007/s00011-012-0458-2. Epub 2012 Mar 18. Inflamm Res. 2012. PMID: 22427230
-
IL-10 implications in psoriasis.Int J Health Sci (Qassim). 2008 Jan;2(1):53-8. Int J Health Sci (Qassim). 2008. PMID: 21475472 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials